DSG’s eCaseLink™ Electronic
Data Capture (EDC) and data
management are currently being used by a biotechnology company for
two current phase 2 and phase 2a clinical trials for treatments of
progressive and chronic kidney disease. The company uses DSG’s
eCaseLink™ to automate and manage the data collection process during the
clinical trial lifecycle. In addition, DSG combines data management
services with eCaseLink™ to seamlessly optimize data collection and
analysis.
“Partnering with innovative drug companies like this, helping to find
ways to help those suffering from progressive and chronic kidney
disease, is an ideal way for DSG’s unique eCaseLink™ EDC system to be
employed in clinical trials”
The result is clean clinical trial data, collected and analyzed
efficiently. This accelerates the clinical trial process, helping to
safely speed these treatments to those who need them.
The phase 2 study, is a new treatment that may help people in the early
stage of diabetic
nephropathy, a progressive kidney disease. The second study,
currently in phase 2a, is a treatment for anemia
in chronic kidney disease.